198 related articles for article (PubMed ID: 33647028)
1. Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection.
Mohamed H; Clemen R; Freund E; Lackmann JW; Wende K; Connors J; Haddad EK; Dampier W; Wigdahl B; Miller V; Bekeschus S; Krebs FC
PLoS One; 2021; 16(3):e0247125. PubMed ID: 33647028
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory Effects of Non-Thermal Plasma in a Model for Latent HIV-1 Infection: Implications for an HIV-1-Specific Immunotherapy.
Mohamed H; Berman R; Connors J; Haddad EK; Miller V; Nonnemacher MR; Dampier W; Wigdahl B; Krebs FC
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672628
[TBL] [Abstract][Full Text] [Related]
3. Combination of CD8β Depletion and Interleukin-15 Superagonist N-803 Induces Virus Reactivation in Simian-Human Immunodeficiency Virus-Infected, Long-Term ART-Treated Rhesus Macaques.
McBrien JB; Wong AKH; White E; Carnathan DG; Lee JH; Safrit JT; Vanderford TH; Paiardini M; Chahroudi A; Silvestri G
J Virol; 2020 Sep; 94(19):. PubMed ID: 32669328
[TBL] [Abstract][Full Text] [Related]
4. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
[TBL] [Abstract][Full Text] [Related]
5. Alternate NF-κB-Independent Signaling Reactivation of Latent HIV-1 Provirus.
Acchioni C; Remoli AL; Marsili G; Acchioni M; Nardolillo I; Orsatti R; Farcomeni S; Palermo E; Perrotti E; Barreca ML; Sabatini S; Sandini S; Parolin C; Lin R; Borsetti A; Hiscott J; Sgarbanti M
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243131
[TBL] [Abstract][Full Text] [Related]
6. Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4
Madrid-Elena N; García-Bermejo ML; Serrano-Villar S; Díaz-de Santiago A; Sastre B; Gutiérrez C; Dronda F; Coronel Díaz M; Domínguez E; López-Huertas MR; Hernández-Novoa B; Moreno S
J Virol; 2018 May; 92(9):. PubMed ID: 29444937
[TBL] [Abstract][Full Text] [Related]
7. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
[TBL] [Abstract][Full Text] [Related]
8. Galectin-9 Mediates HIV Transcription by Inducing TCR-Dependent ERK Signaling.
Colomb F; Giron LB; Premeaux TA; Mitchell BI; Niki T; Papasavvas E; Montaner LJ; Ndhlovu LC; Abdel-Mohsen M
Front Immunol; 2019; 10():267. PubMed ID: 30842775
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of Endogenous HIV-1 Reactivation by Endocervical Epithelial Cells.
Gornalusse GG; Valdez R; Fenkart G; Vojtech L; Fleming LM; Pandey U; Hughes SM; Levy CN; Dela Cruz EJ; Calienes FL; Kirby AC; Fialkow MF; Lentz GM; Wagoner J; Jing L; Koelle DM; Polyak SJ; Fredricks DN; McElrath MJ; Wald A; Hladik F
J Virol; 2020 Apr; 94(9):. PubMed ID: 32051273
[TBL] [Abstract][Full Text] [Related]
10. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-15-Stimulated Natural Killer Cells Clear HIV-1-Infected Cells following Latency Reversal
Garrido C; Abad-Fernandez M; Tuyishime M; Pollara JJ; Ferrari G; Soriano-Sarabia N; Margolis DM
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593039
[TBL] [Abstract][Full Text] [Related]
12. Toll-Like Receptor 7 Agonist GS-9620 Induces HIV Expression and HIV-Specific Immunity in Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.
Tsai A; Irrinki A; Kaur J; Cihlar T; Kukolj G; Sloan DD; Murry JP
J Virol; 2017 Apr; 91(8):. PubMed ID: 28179531
[TBL] [Abstract][Full Text] [Related]
13. Humanized Mouse Model of HIV-1 Latency with Enrichment of Latent Virus in PD-1
Llewellyn GN; Seclén E; Wietgrefe S; Liu S; Chateau M; Pei H; Perkey K; Marsden MD; Hinkley SJ; Paschon DE; Holmes MC; Zack JA; Louie SG; Haase AT; Cannon PM
J Virol; 2019 May; 93(10):. PubMed ID: 30842333
[TBL] [Abstract][Full Text] [Related]
14. Small Molecule Inhibitors of BAF; A Promising Family of Compounds in HIV-1 Latency Reversal.
Stoszko M; De Crignis E; Rokx C; Khalid MM; Lungu C; Palstra RJ; Kan TW; Boucher C; Verbon A; Dykhuizen EC; Mahmoudi T
EBioMedicine; 2016 Jan; 3():108-121. PubMed ID: 26870822
[TBL] [Abstract][Full Text] [Related]
15. PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.
He Z; Jing S; Yang T; Chen J; Huang F; Zhang W; Peng Z; Liu B; Ma X; Wu L; Pan T; Zhang X; Li L; Cai W; Tang X; Zhang J; Zhang H
J Virol; 2020 May; 94(10):. PubMed ID: 32161174
[TBL] [Abstract][Full Text] [Related]
16. Thiostrepton Reactivates Latent HIV-1 through the p-TEFb and NF-κB Pathways Mediated by Heat Shock Response.
Peng W; Hong Z; Chen X; Gao H; Dai Z; Zhao J; Liu W; Li D; Deng K
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094131
[TBL] [Abstract][Full Text] [Related]
17. In vivo analysis of the effect of panobinostat on cell-associated HIV RNA and DNA levels and latent HIV infection.
Tsai P; Wu G; Baker CE; Thayer WO; Spagnuolo RA; Sanchez R; Barrett S; Howell B; Margolis D; Hazuda DJ; Archin NM; Garcia JV
Retrovirology; 2016 May; 13(1):36. PubMed ID: 27206407
[TBL] [Abstract][Full Text] [Related]
18. Plasma Extracellular Vesicles Enhance HIV-1 Infection of Activated CD4
Okoye I; Xu L; Oyegbami O; Shahbaz S; Pink D; Gao P; Sun X; Elahi S
Front Immunol; 2021; 12():697604. PubMed ID: 34249000
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
20. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
